{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T04:46:40Z","timestamp":1777956400706,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["62303152"],"award-info":[{"award-number":["62303152"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.isci.2025.112849","type":"journal-article","created":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T02:44:00Z","timestamp":1749264240000},"page":"112849","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Deep learning assisted non-invasive lymph node burden evaluation and CDK4\/6i administration in luminal breast cancer"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2745-0194","authenticated-orcid":false,"given":"Yuhan","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinlin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zecheng","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yidong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2025.112849_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.isci.2025.112849_bib2","first-page":"688","article-title":"The natural history of hormone receptor\u2013positive breast cancer","volume":"26","author":"Lim","year":"2012","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.isci.2025.112849_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.breast.2021.02.009","article-title":"Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: a systematic review and meta-analysis","volume":"57","author":"Salvo","year":"2021","journal-title":"Breast (Edinb.)"},{"key":"10.1016\/j.isci.2025.112849_bib4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/jnci\/djab202","article-title":"The incidence of breast cancer recurrence 10-32 years after primary diagnosis","volume":"114","author":"Pedersen","year":"2022","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.isci.2025.112849_bib5","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41568-022-00456-3","article-title":"Targeting CDK4 and CDK6 in cancer","volume":"22","author":"Goel","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2025.112849_bib6","first-page":"3638","article-title":"MONARCH 3: Abemaciclib as initial therapy for advanced breast cancer","volume":"35","author":"Goetz","year":"2017","journal-title":"J. Clin. Orthod."},{"key":"10.1016\/j.isci.2025.112849_bib7","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1056\/NEJMoa2305488","article-title":"Ribociclib plus endocrine therapy in early breast cancer","volume":"390","author":"Slamon","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2025.112849_bib8","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S1470-2045(18)30380-2","article-title":"IBCSG 2301: axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial","volume":"19","author":"Galimberti","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.isci.2025.112849_bib9","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.isci.2025.112849_bib10","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJMoa2313487","article-title":"Omitting axillary dissection in breast cancer with sentinel-node metastases","volume":"390","author":"De Boniface","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2025.112849_bib11","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/jamaoncol.2023.3759","article-title":"Sentinel lymph node biopsy vs no axillary surgery in patients with small breast cancer and negative results on ultrasonography of axillary lymph nodes: the SOUND randomized clinical trial","volume":"9","author":"Gentilini","year":"2023","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.isci.2025.112849_bib12","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S1470-2045(24)00350-4","article-title":"Completion axillary lymph node dissection for the identification of pN2\u20133 status as an indication for adjuvant CDK4\/6 inhibitor treatment: a post-hoc analysis of the randomised, phase 3 SENOMAC trial","volume":"25","author":"De Boniface","year":"2024","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.isci.2025.112849_bib13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.clinimag.2023.05.007","article-title":"Emerging uses of artificial intelligence in breast and axillary ultrasound","volume":"100","author":"Trepanier","year":"2023","journal-title":"Clin. Imaging"},{"key":"10.1016\/j.isci.2025.112849_bib14","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1148\/radiol.2015151169","article-title":"Radiomics: images are more than pictures, they are data","volume":"278","author":"Gillies","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.isci.2025.112849_bib15","article-title":"Mask R-CNN","author":"He","year":"2017","journal-title":"arXiv"},{"key":"10.1016\/j.isci.2025.112849_bib16","article-title":"Cascade R-CNN: delving into high quality object detection","author":"Cai","year":"2017","journal-title":"arXiv"},{"key":"10.1016\/j.isci.2025.112849_bib17","article-title":"A ConvNet for the 2020s","author":"Liu","year":"2022","journal-title":"arXiv"},{"key":"10.1016\/j.isci.2025.112849_bib18","article-title":"YOLOX: exceeding YOLO series in 2021","author":"Ge","year":"2021","journal-title":"arXiv"},{"key":"10.1016\/j.isci.2025.112849_bib19","article-title":"DINO: DETR with improved denoising anchor boxes for end-to-end object detection","author":"Zhang","year":"2022","journal-title":"arXiv"},{"key":"10.1016\/j.isci.2025.112849_bib20","article-title":"DETRs beat YOLOs on real-time object detection","author":"Zhao","year":"2024","journal-title":"arXiv"},{"key":"10.1016\/j.isci.2025.112849_bib21","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.breast.2021.07.015","article-title":"Feasibility and reliability of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients with positive axillary nodes at initial diagnosis: An up-to-date meta-analysis of 3,578 patients","volume":"59","author":"Cao","year":"2021","journal-title":"Breast (Edinb.)"},{"key":"10.1016\/j.isci.2025.112849_bib22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s40477-022-00755-3","article-title":"Diagnostic performance of mammography and ultrasound in breast cancer: a systematic review and meta-analysis","volume":"26","author":"Tadesse","year":"2023","journal-title":"J. Ultrasound"},{"key":"10.1016\/j.isci.2025.112849_bib23","first-page":"2875","article-title":"MONARCH 2: abemaciclib in combination with fulvestrant in women with HR+\/HER2\u2212 advanced breast cancer who had progressed while receiving endocrine therapy","volume":"35","author":"Sledge","year":"2017","journal-title":"J. Clin. Orthod."},{"key":"10.1016\/j.isci.2025.112849_bib24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(11)70336-9","article-title":"Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial","volume":"13","author":"Gianni","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.isci.2025.112849_bib25","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1470-2045(16)00163-7","article-title":"5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial","volume":"17","author":"Gianni","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.isci.2025.112849_bib26","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1001\/jamasurg.2024.3944","article-title":"Prediction of high nodal burden in patients with sentinel node-positive luminal ERBB2-negative breast cancer","volume":"159","author":"Skarping","year":"2024","journal-title":"JAMA Surg."},{"key":"10.1016\/j.isci.2025.112849_bib27","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1136\/jclinpath-2017-204981","article-title":"Diagnostic concordance of reporting lymphovascular invasion in breast cancer","volume":"71","author":"Rakha","year":"2018","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.isci.2025.112849_bib28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nrc3677","article-title":"Lymphangiogenesis and lymphatic vessel remodelling in cancer","volume":"14","author":"Stacker","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2025.112849_bib29","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.surg.2005.12.008","article-title":"VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survival","volume":"139","author":"Schoppmann","year":"2006","journal-title":"Surgery"},{"key":"10.1016\/j.isci.2025.112849_bib30","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1109\/TIP.2022.3193288","article-title":"MATR: multimodal medical image fusion via multiscale adaptive transformer","volume":"31","author":"Tang","year":"2022","journal-title":"IEEE Trans. Image Process."},{"key":"10.1016\/j.isci.2025.112849_bib31","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.isci.2025.112849_bib32","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.diii.2017.01.001","article-title":"BI-RADS \u00ae fifth edition: a summary of changes","volume":"98","author":"Spak","year":"2017","journal-title":"Diagn. Interv. Imaging"},{"key":"10.1016\/j.isci.2025.112849_bib33","first-page":"290","article-title":"Breast cancer-major changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Giuliano","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.isci.2025.112849_bib34","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1200\/JCO.22.02864","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: ASCO-College of American Pathologists Guideline Update","volume":"41","author":"Wolff","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.isci.2025.112849_bib35","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/jnci\/djaa201","article-title":"Assessment of Ki67 in breast cancer: updated recommendations from the International Ki67 in Breast Cancer Working Group","volume":"113","author":"Nielsen","year":"2021","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.isci.2025.112849_bib37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/his.14091","article-title":"The 2019 World Health Organization classification of tumours of the breast","volume":"77","author":"Tan","year":"2020","journal-title":"Histopathology (Oxf.)"},{"key":"10.1016\/j.isci.2025.112849_bib38","series-title":"ACR BI-RADS\u00ae Atlas: Breast Imaging Reporting and Data System (5th ed.)","year":"2022"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225011101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225011101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T02:16:25Z","timestamp":1777947385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004225011101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2589004225011101"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2025.112849","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deep learning assisted non-invasive lymph node burden evaluation and CDK4\/6i administration in luminal breast cancer","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2025.112849","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112849"}}